CAR-T in Multiple Myeloma: Balancing Innovation, Toxicity, and Access – A Dialogue Between Prof. Robin Foà, Dr. Filippo Milano and Dr. Rahul Banerjee

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/6d/0e/be/6d0ebe06-0086-f178-f913-75ebfef5db1f/mza_1013507527412833612.jpg/600x600bb.jpg

Hematology Pills

Mattioli Health

9 episodes

1 week ago

Hematology Pills is a new format based on monthly discussions between Prof. Robin Foà (Rome) and Dr. Filippo Milano (Seattle). Each episode explores the latest breakthroughs in gene therapy, immunotherapy, and clinical innovation, while addressing also ethical and practical challenges that shape the field. Our podcast offers a clear and compelling look at the evolving landscape of blood disorders and treatments for hematologists, researchers and healthcare professionals. Stay informed, inspired, and connected with Hematology Pills – a source off hematology updates, one episode at a time.

Medicine

Health & Fitness

RSS

All content for Hematology Pills is the property of Mattioli Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43074747/43074747-1739953567941-05645e7877ada.jpg

CAR-T in Multiple Myeloma: Balancing Innovation, Toxicity, and Access – A Dialogue Between Prof. Robin Foà, Dr. Filippo Milano and Dr. Rahul Banerjee

Hematology Pills

22 minutes 38 seconds

7 months ago

CAR-T in Multiple Myeloma: Balancing Innovation, Toxicity, and Access – A Dialogue Between Prof. Robin Foà, Dr. Filippo Milano and Dr. Rahul Banerjee

In this episode of Hematology Pills, Professor Robin Foà speaks with Dr. Filippo Milano and Dr. Rahul Banerjee about the current role of CAR-T cell therapy in the treatment of multiple myeloma. The discussion touches on key aspects such as therapeutic potential, toxicity management, and the practical issues related to access. Aimed at clinicians and healthcare professionals, the episode provides a clear overview of both opportunities and limitations of this evolving approach.